Asthika Goonewardene
Stock Analyst at Truist Securities
(2.08)
# 2,947
Out of 5,154 analysts
89
Total ratings
40.7%
Success rate
-5.63%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Asthika Goonewardene
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACLX Arcellx | Downgrades: Hold | $134 → $120 | $114.33 | +4.96% | 6 | Feb 24, 2026 | |
| ZYME Zymeworks | Initiates: Buy | $40 | $24.08 | +66.11% | 1 | Dec 17, 2025 | |
| AVBP ArriVent BioPharma | Initiates: Buy | $43 | $23.43 | +83.53% | 1 | Nov 25, 2025 | |
| GMAB Genmab | Reiterates: Buy | $49 → $48 | $27.06 | +77.38% | 16 | Nov 7, 2025 | |
| GILD Gilead Sciences | Reiterates: Buy | $127 → $145 | $143.93 | +0.74% | 3 | Nov 3, 2025 | |
| RCUS Arcus Biosciences | Reiterates: Buy | $32 → $39 | $22.11 | +76.39% | 2 | Oct 7, 2025 | |
| JANX Janux Therapeutics | Initiates: Buy | $100 | $13.84 | +622.54% | 1 | Sep 10, 2025 | |
| RVMD Revolution Medicines | Initiates: Buy | $99 | $98.40 | +0.61% | 1 | Sep 5, 2025 | |
| EXEL Exelixis | Maintains: Buy | $56 → $49 | $41.55 | +17.94% | 11 | Jul 29, 2025 | |
| BNTX BioNTech SE | Reiterates: Buy | $151 → $155 | $101.50 | +52.71% | 3 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $71 | $18.97 | +274.28% | 2 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $10 | $2.30 | +334.78% | 7 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $1.51 | +562.25% | 4 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $15 | $5.13 | +192.40% | 6 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $15.11 | +131.63% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $180 → $150 | $25.29 | +493.12% | 6 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $2.08 | +92.31% | 5 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 | $1.82 | +943.96% | 3 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $432 | $7.29 | +5,825.93% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Hold | $120 | $8.87 | +1,252.87% | 1 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $100 → $60 | $1.21 | +4,858.68% | 3 | Aug 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $228 → $180 | $12.07 | +1,391.30% | 4 | Aug 23, 2022 |
Arcellx
Feb 24, 2026
Downgrades: Hold
Price Target: $134 → $120
Current: $114.33
Upside: +4.96%
Zymeworks
Dec 17, 2025
Initiates: Buy
Price Target: $40
Current: $24.08
Upside: +66.11%
ArriVent BioPharma
Nov 25, 2025
Initiates: Buy
Price Target: $43
Current: $23.43
Upside: +83.53%
Genmab
Nov 7, 2025
Reiterates: Buy
Price Target: $49 → $48
Current: $27.06
Upside: +77.38%
Gilead Sciences
Nov 3, 2025
Reiterates: Buy
Price Target: $127 → $145
Current: $143.93
Upside: +0.74%
Arcus Biosciences
Oct 7, 2025
Reiterates: Buy
Price Target: $32 → $39
Current: $22.11
Upside: +76.39%
Janux Therapeutics
Sep 10, 2025
Initiates: Buy
Price Target: $100
Current: $13.84
Upside: +622.54%
Revolution Medicines
Sep 5, 2025
Initiates: Buy
Price Target: $99
Current: $98.40
Upside: +0.61%
Exelixis
Jul 29, 2025
Maintains: Buy
Price Target: $56 → $49
Current: $41.55
Upside: +17.94%
BioNTech SE
Jun 3, 2025
Reiterates: Buy
Price Target: $151 → $155
Current: $101.50
Upside: +52.71%
May 14, 2025
Maintains: Buy
Price Target: $88 → $71
Current: $18.97
Upside: +274.28%
May 14, 2025
Maintains: Buy
Price Target: $14 → $10
Current: $2.30
Upside: +334.78%
Apr 1, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $1.51
Upside: +562.25%
Mar 3, 2025
Maintains: Buy
Price Target: $25 → $15
Current: $5.13
Upside: +192.40%
Jan 8, 2025
Initiates: Buy
Price Target: $35
Current: $15.11
Upside: +131.63%
Aug 16, 2024
Maintains: Buy
Price Target: $180 → $150
Current: $25.29
Upside: +493.12%
May 21, 2024
Maintains: Buy
Price Target: $5 → $4
Current: $2.08
Upside: +92.31%
May 16, 2024
Maintains: Buy
Price Target: $19
Current: $1.82
Upside: +943.96%
Sep 6, 2023
Reiterates: Buy
Price Target: $432
Current: $7.29
Upside: +5,825.93%
Apr 5, 2023
Reinstates: Hold
Price Target: $120
Current: $8.87
Upside: +1,252.87%
Aug 23, 2022
Maintains: Hold
Price Target: $100 → $60
Current: $1.21
Upside: +4,858.68%
Aug 23, 2022
Maintains: Buy
Price Target: $228 → $180
Current: $12.07
Upside: +1,391.30%